Ottawa, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The global clinical data analytics market size is calculated at USD 132.89 billion in 2026 and is expected to reach around USD 930.01 billion by 2034, growing ...

When choosing infrastructure to support clinical analytics, many healthcare organizations use a monolithic and siloed approach, which can hinder implementation and limit opportunities to scale up and ...

The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.

Participation supports national effort to unlock cures for pediatric cancer using artificial intelligence. NASHVILLE, ...

Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual ...

In today’s ultra-competitive global marketplace, life sciences companies are continually seeking ways to improve their research effectiveness and efficiency. Increasingly, real-world data (RWD) is ...

Health systems are adopting a range of strategies to strengthen collaboration between clinical and supply chain teams, such as implementing formal governance structures, data-driven disruption ...

The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The AI-based clinical trials market is driving a fundamental transformation in ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

(MENAFN- GlobeNewsWire - Nasdaq) The global clinical data analytics market size was valued at USD 104.16 billion in 2025 and is predicted to hit around USD 930.01 billion by 2034, rising at a 27.57% ...